女性ヘルスケア市場：世界の産業規模、シェア、動向、機会、予測、薬剤別、用途別、地域別、競合別、2019年～2029年

女性ヘルスケアの世界市場規模は2023年に95億2,000万米ドルとなり、予測期間では2029年までCAGR 5.25％で安定した成長が予測されています。

世界の女性ヘルスケア市場は、認知度の向上、技術の進歩、女性の健康と福祉重視の高まりなどの要因が重なり、近年著しい成長と進化を遂げています。世界中の社会が女性の健康を優先することの重要性を認識し続ける中、女性ヘルスケア市場はイノベーションと投資の焦点となっています。

テクノロジーの進歩は、女性ヘルスケア市場の形成に極めて重要な役割を果たしています。遠隔医療やデジタルヘルスプラットフォームからウェアラブルデバイスや個別化医療まで、テクノロジーは女性が自分の健康と幸福をコントロールする力を与えています。遠隔モニタリング、バーチャル診察、健康アプリはますます普及し、便利で利用しやすいヘルスケアソリューションを提供しています。予防ヘルスケアに重点が置かれるようになり、女性がより健康的なライフスタイルを採用し、定期的な検診を受けることが奨励されています。乳がんや子宮頸がんなどの疾病の早期発見を促進する取り組みが世界的に支持されています。予防医療へのシフトは、慢性疾患の負担を軽減し、全体的な健康アウトカムを改善することを目的としています。女性の健康問題に対する意識の高まりは、ヘルスケアに対するより多くの情報と積極的なアプローチにつながっています。月経の健康、不妊症、更年期障害などの課題がオープンに議論されるようになり、社会のタブーに課題し、女性のヘルスケアニーズのより包括的な理解に貢献しています。

市場促進要因

ライフスタイルと栄養の変化が世界の女性ヘルスケア市場を牽引しています。

可処分所得の増加が女性ヘルスケアの世界市場を牽引

主な市場課題

健康格差

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別（エビスタ、XGEVA、プロリア、ミレーナ、ゾメタ、レクラスト/アクラスタ、ミナストリン24Fe、ヌーバリング、フォルテオ、プレマリン、アクトンエル、オルソトリサイロ（28））
  • 用途別（ホルモン不妊症、閉経後骨粗鬆症、子宮内膜症、避妊薬、更年期障害、多嚢胞性卵巣症候群、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ
  • 薬剤別
  • 用途別
  • 地域別

第5章 アジア太平洋地域の女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの女性ヘルスケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の女性ヘルスケア市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Bayer AG
• Cardinal Health
• Allergan plc.
• Merck & Co.
• Pfizer Inc.
• Amgen Inc.
• Agile Therapeutics Inc.
• Ferring Pharmaceuticals
• Mylan N.V.
• Lupin Limited
• Blairex Laboratories
• Apothecus Pharmaceutical

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Women Healthcare Market was valued at USD 9.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global women's healthcare market has witnessed significant growth and evolution in recent years, driven by a combination of factors such as increasing awareness, technological advancements, and a growing emphasis on women's health and well-being. As societies around the world continue to recognize the importance of prioritizing women's health, the women's healthcare market has become a focal point for innovation and investment.

Advances in technology have played a pivotal role in shaping the women's healthcare market. From telemedicine and digital health platforms to wearable devices and personalized medicine, technology has empowered women to take control of their health and well-being. Remote monitoring, virtual consultations, and health apps are becoming increasingly popular, providing convenient and accessible healthcare solutions. There is a growing emphasis on preventive healthcare, encouraging women to adopt healthier lifestyles and undergo regular screenings. Initiatives promoting early detection of diseases such as breast and cervical cancer have gained traction globally. The shift towards preventive care aims to reduce the burden of chronic conditions and improve overall health outcomes. Increased awareness of women's health issues has led to a more informed and proactive approach towards healthcare. Issues such as menstrual health, fertility, and menopause are now being discussed openly, challenging societal taboos and contributing to a more comprehensive understanding of women's healthcare needs.

Key Market Drivers

Changing Lifestyles and Nutrition are Driving the Global Women Healthcare Market.

The global women's healthcare market is undergoing a significant transformation, driven by changing lifestyles and a growing awareness of the critical role that nutrition plays in women's health. As societies evolve, so do the healthcare needs of women, prompting a surge in demand for innovative solutions and comprehensive care. The 21st century has witnessed a remarkable shift in the lifestyles of women worldwide. Factors such as increased urbanization, rising employment opportunities, and changing societal norms have led to alterations in daily routines and habits. While these changes bring new opportunities, they also present challenges to women's health. Sedentary lifestyles, stress, and inadequate sleep have become common features, contributing to various health issues. This shift has fueled a demand for healthcare solutions that address the specific needs of women in today's fast-paced world. Women are increasingly seeking healthcare services that provide holistic and personalized approaches to manage their health, taking into account their unique biological and lifestyle factors.

Nutrition is a cornerstone of overall health, and its significance is particularly pronounced in women's well-being. Proper nutrition is essential for the prevention of chronic diseases, the maintenance of a healthy weight, and the support of reproductive health. The global awareness of the intricate relationship between nutrition and women's health has led to a surge in demand for nutritional guidance, dietary supplements, and specialized healthcare products. The prevalence of conditions such as osteoporosis, anemia, and hormonal imbalances has led to a growing emphasis on nutrition as a preventive and therapeutic measure. Women are increasingly turning to healthcare providers and nutritionists for guidance on balanced diets, micronutrient supplementation, and lifestyle modifications that can positively impact their health.

The intersection of changing lifestyles and the focus on nutrition has created a dynamic landscape in the global women's healthcare market. Market players are responding to this shift by developing a wide array of products and services that cater to the unique healthcare needs of women. From fertility solutions and hormonal therapies to nutritionally fortified supplements and digital health platforms, the market is witnessing a surge in innovation. Moreover, the integration of technology, such as wearable devices and health apps, allows women to monitor and manage their health in real-time, empowering them to make informed decisions about their well-being. This convergence of healthcare and technology is reshaping the delivery of women's healthcare services, making them more accessible, personalized, and preventive.

Increasing Disposable Income is Driving the Global Women Healthcare Market

In recent years, a notable trend has emerged in the global healthcare sector - the surge in demand for women's healthcare services. This trend is closely linked to the increase in disposable income among women worldwide. As women gain greater financial independence, they are prioritizing their health and well-being, leading to a substantial growth in the global women's healthcare market. With higher disposable incomes, women have greater access to comprehensive reproductive health services. This includes advanced fertility treatments, family planning options, and prenatal care. As women are empowered to make choices regarding their reproductive health, the demand for specialized healthcare services in this domain has significantly increased.

Rising disposable incomes have enabled women to invest in preventive healthcare measures. Routine screenings, vaccinations, and health check-ups are now more affordable and accessible, leading to the early detection and prevention of various health conditions. This shift towards preventive care has positively impacted the overall well-being of women. The influx of disposable income has driven significant investments in research and development within the women's healthcare sector. This has resulted in technological advancements such as innovative diagnostic tools, minimally invasive surgical procedures, and personalized treatment plans. These developments enhance the overall quality of care for women. Women with higher disposable incomes are increasingly seeking holistic healthcare services that address both physical and mental well-being. This includes wellness programs, stress management, and mental health support tailored to the unique needs of women. As a result, the market for these services has expanded substantially. The aesthetic aspect of women's healthcare has also witnessed a surge in demand. Procedures such as cosmetic surgery, dermatological treatments, and other aesthetic interventions have become more accessible to women with increased disposable incomes. This reflects a broader societal shift towards self-care and personal grooming.

Key Market Challenges

Health Disparities

Health disparities among women remain a pervasive challenge in the global healthcare landscape. While advancements in medical science have led to significant improvements in women's health, a closer look reveals that not all women benefit equally. Disparities in healthcare access, treatment outcomes, and preventive care persist, posing a substantial hurdle to achieving comprehensive well-being for women worldwide. Health disparities refer to the differences in health outcomes and healthcare access among different populations. These differences are often influenced by various factors, including socioeconomic status, race, ethnicity, geographic location, education, and more. Unfortunately, these disparities are glaringly evident in the realm of women's healthcare, affecting everything from routine medical care to specialized treatments.

Key Market Trends

Technological Advancements

In recent years, the healthcare industry has experienced a paradigm shift, with technological advancements playing a pivotal role in transforming the landscape of women's healthcare. The Global Women's Healthcare Market has been witnessing a surge in innovation, fueled by breakthroughs in medical technology, data analytics, and telehealth solutions. Technological advancements have ushered in an era of precision medicine, allowing healthcare providers to tailor treatment plans based on an individual's genetic makeup, lifestyle, and environmental factors. In women's healthcare, this approach is particularly beneficial for conditions such as breast and ovarian cancers. Genetic testing and personalized treatment options empower women to make informed decisions about their health, leading to more effective and targeted interventions.

The rise of telehealth has been a game-changer in women's healthcare, providing convenient and accessible options for consultations, monitoring, and follow-up care. Telehealth platforms enable women to connect with healthcare professionals from the comfort of their homes, overcoming geographical barriers and improving the overall patient experience. Remote monitoring devices, such as wearable sensors, allow continuous tracking of vital signs and other health metrics, facilitating early detection of potential issues. Advances in fertility treatments and reproductive health technologies have significantly expanded options for women planning to start a family. Assisted reproductive technologies, including in vitro fertilization (IVF) and preimplantation genetic testing (PGT), have become more sophisticated and effective. Additionally, digital health tools and apps help women track their menstrual cycles, ovulation, and fertility windows, empowering them to take charge of their reproductive health. There has been a surge in digital health platforms dedicated to women's wellness, covering a broad spectrum of health concerns from pregnancy and maternal care to menopause and beyond. These platforms provide evidence-based information, personalized advice, and community support, fostering a holistic approach to women's health. From mental health apps to nutrition and fitness trackers, digital tools are empowering women to proactively manage their well-being. Artificial intelligence (AI) and machine learning are revolutionizing diagnostics in women's healthcare. These technologies enhance the accuracy and efficiency of medical imaging, such as mammography and ultrasound, leading to early detection of conditions like breast cancer. AI algorithms also assist healthcare professionals in analyzing vast amounts of patient data, enabling more precise diagnoses and treatment recommendations.

Segmental Insights

Drug Insights

Based on the category of drug, prolia emerged as the dominant player in the global market for Women Healthcare in 2023. Prolia, also known as denosumab, is a monoclonal antibody designed to treat osteoporosis in postmenopausal women. Developed by Amgen, this cutting-edge medication is a RANK ligand (RANKL) inhibitor, disrupting the biological pathway responsible for bone resorption. By inhibiting RANKL, Prolia effectively reduces the risk of fractures and enhances bone density. Osteoporosis, characterized by weakened bones and an increased susceptibility to fractures, particularly affects postmenopausal women due to hormonal changes that occur during menopause. Prolia has emerged as a frontrunner in osteoporosis treatment, offering a novel approach to managing bone health. The global prevalence of osteoporosis has led to an increased demand for effective treatments, and Prolia has positioned itself as a go-to solution. Prolia's success in the market can be attributed to its clinical efficacy and safety profile. Numerous clinical trials have demonstrated its ability to significantly increase bone mineral density and reduce the risk of fractures in postmenopausal women. Additionally, its mode of action, targeting RANKL, provides a unique advantage over traditional osteoporosis treatments.

The convenience of Prolia is another factor contributing to its dominance. Unlike oral medications that require daily or weekly administration, Prolia is administered through a subcutaneous injection once every six months. This not only enhances patient compliance but also ensures a consistent and controlled dosage. Prolia's success is not limited to a specific region, as it has achieved widespread acceptance globally. The drug has secured regulatory approvals from health authorities in various countries, attesting to its safety and efficacy. The expanding market reach of Prolia has positioned it as a frontrunner in the global women's healthcare market, capturing the attention of healthcare professionals, patients, and investors alike.

Regional Insights

North America emerged as the dominant region in the global Women Healthcare market in 2023, holding the largest market share in terms of value. North America has been at the forefront of adopting and developing cutting-edge medical technologies. The integration of technology in healthcare has resulted in improved diagnostics, personalized treatment plans, and enhanced patient care. The region's continuous investment in research and development has led to the creation of innovative solutions for various women's health issues. The United States and Canada boast advanced healthcare infrastructures that provide comprehensive services for women across all stages of life. Accessible healthcare facilities, well-equipped hospitals, and specialized clinics contribute to the region's dominance in offering a wide array of women's healthcare services.

Key Market Players

Bayer AG

Cardinal Health

Allergan plc.

Merck & Co.

Pfizer Inc.

Amgen Inc.

Agile Therapeutics Inc.

Ferring Pharmaceuticals

Mylan N.V.

Lupin Limited

Blairex Laboratories

Apothecus Pharmaceutical

Report Scope:

In this report, the Global Women Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Women Healthcare Market, By Drug:

EVISTA XGEVA Prolia Mirena Zometa Reclast/Aclasta Minastrin 24 Fe NuvaRing FORTEO Premarin ACTONEL ORTHO TRI-CY LO (28)

Women Healthcare Market, By Application:

Hormonal Infertility Postmenopausal Osteoporosis Endometriosis Contraceptives Menopause Polycystic Ovary Syndrome Others

Women Healthcare Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Women Healthcare Market.

Available Customizations:

Global Women Healthcare market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Women Healthcare Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, ORTHO TRI-CY LO (28))
  • 4.2.2. By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Drug
  • 4.3.2. By Application
  • 4.3.3. By Region

5. Asia Pacific Women Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug
  • 5.2.2. By Application
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Women Healthcare Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Drug
      • 5.3.1.2.2. By Application
  • 5.3.2. India Women Healthcare Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Drug
      • 5.3.2.2.2. By Application
  • 5.3.3. Australia Women Healthcare Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Drug
      • 5.3.3.2.2. By Application
  • 5.3.4. Japan Women Healthcare Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Drug
      • 5.3.4.2.2. By Application
  • 5.3.5. South Korea Women Healthcare Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Drug
      • 5.3.5.2.2. By Application

6. Europe Women Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Women Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug
      • 6.3.1.2.2. By Application
  • 6.3.2. Germany Women Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug
      • 6.3.2.2.2. By Application
  • 6.3.3. Spain Women Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug
      • 6.3.3.2.2. By Application
  • 6.3.4. Italy Women Healthcare Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Drug
      • 6.3.4.2.2. By Application
  • 6.3.5. United Kingdom Women Healthcare Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Drug
      • 6.3.5.2.2. By Application

7. North America Women Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Women Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug
      • 7.3.1.2.2. By Application
  • 7.3.2. Mexico Women Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug
      • 7.3.2.2.2. By Application
  • 7.3.3. Canada Women Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug
      • 7.3.3.2.2. By Application

8. South America Women Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Women Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug
      • 8.3.1.2.2. By Application
  • 8.3.2. Argentina Women Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug
      • 8.3.2.2.2. By Application
  • 8.3.3. Colombia Women Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug
      • 8.3.3.2.2. By Application

9. Middle East and Africa Women Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Women Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug
      • 9.3.1.2.2. By Application
  • 9.3.2. Saudi Arabia Women Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug
      • 9.3.2.2.2. By Application
  • 9.3.3. UAE Women Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug
      • 9.3.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Women Healthcare Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Bayer AG
  • 14.1.1. Company Snapshot
  • 14.1.2. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Cardinal Health
• 14.3. Allergan plc.
• 14.4. Merck & Co.
• 14.5. Pfizer Inc.
• 14.6. Amgen Inc.
• 14.7. Agile Therapeutics Inc.
• 14.8. Ferring Pharmaceuticals
• 14.9. Mylan N.V.
• 14.10.Lupin Limited
• 14.11.Blairex Laboratories
• 14.12.Apothecus Pharmaceutical

15. Strategic Recommendations

16. About Us & Disclaimer